Liver transplantation: Evolving patient selection criteria

Canadian Journal of Gastroenterology

Volumn 15, Issue 11, 2001, Pages 729-738

  Yu, A S ^a   Ahmed, A ^a   Keeffe, E B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Liver transplantation; United network for organ sharing

Indexed keywords

ARTICLE; CADAVER DONOR; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; GOVERNMENT; HEALTH CARE POLICY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL ETHICS; MODEL; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; TREATMENT OUTCOME; UNITED STATES;

EID: 0035674392     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/743019     Document Type: Article

References (88)

1. National Institutes of Health consensus development conference statement: Liver transplantation, June 20-23, 1983
2. Liver transplantation in the United States from 1987-1998: Updated results from the Pitt-UNOS liver transplant registry
3. Selection of patients for liver transplantation
4. Selection of patients for liver transplantation in 1997 and beyond
5. History of liver and other splanchnic organ transplantation
6. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: A survival report
7. Health-related quality of life after liver transplantation: A meta-analysis
8. Quality of life and cognitive function of liver transplant patients: A prospective study
9. Impact of liver transplantation on health-related quality of life
10. Health-related quality of life in long-term survivors of pediatric liver transplantation
11. Summary of guidelines on organ allocation and patient listing for liver transplantation
12. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases
13. Current indications, contraindications, and timing for liver transplantation
14. Indications for and timing of liver transplantation
15. Recurrent disease after liver transplantation
16. Is retransplantation cost effective?
17. The "arithmetic" of donor liver allocation
18. Resource utilization in liver transplantation: Effects of patient characteristics and clinical practice
19. Evolving trends in liver transplantation: An outcome and charge analysis
20. Liver transplantation for metabolic disease
21. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1
22. Orthotopic liver transplantation for urea cycle enzyme deficiency
23. Liver transplantation for homozygous familial hypercholesterolaemia
24. Cure of hemophilia A by orthotopic liver transplantation
25. Allocation of livers for liver transplantation: Ethics and politics
26. The debate over liver allocation in the United States: The UNOS perspective
27. The rationale for equitable liver allocation
28. Primary graft dysfunction after liver transplantation: From pathogenesis to prevention
29. One thousand liver transplants. The lessons learned
30. Use of fatty donor liver is associated with diminished early patient and graft survival
31. Influence of donor age on graft survival after transplantation - United Network for Organ Sharing Registry
32. Donor age and outcome of liver transplantation
33. Infectivity of hepatic allografts with antibodies to hepatitis B virus
34. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors
35. Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy
36. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
37. Split liver transplantation
38. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants
39. Split liver transplantation: King's College Hospital experience
40. Liver transplantation from live donors
41. Successful living-related partial liver transplantation to an adult patient
42. Living related liver transplantation for children younger than one year old
43. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe
44. Right lobe living donor liver transplantation: A review
45. Adult-to-adult living donor liver transplantation using extended right lobe grafts
46. Applicability of living donor liver transplantation to high-urgency patients
47. Evaluation of 100 patients for living donor liver transplantation
48. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
49. Prognosis and life expectancy in chronic liver disease
50. Compensated cirrhosis: Natural history and prognostic factors
51. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites
52. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
53. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial
54. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
55. Liver transplantation for fulminant hepatic failure
56. Etiology and outcome for 295 patients with acute liver failure in the United States
57. Early indicators of prognosis in fulminant hepatic failure
58. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: A prospective study
59. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria
60. Use and validation of selection criteria for liver transplantation in acute liver failure
61. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure
62. Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure
63. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
64. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis
65. Efficiency of liver transplantation in patients with primary biliary cirrhosis
66. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis
67. Prognosis in primary biliary cirrhosis: Model for decision making
68. Optimal timing of liver transplantation for primary biliary cirrhosis
69. Confirmation of the role of the Mayo risk score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis
70. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
71. Primary sclerosing cholangitis: Refinement and validation of survival models
72. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis
73. Primary sclerosing cholangitis: Liver transplantation or biliary surgery
74. Clinicopathologic features of the syndrome of primary sclerosing cholangitis
75. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology
76. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation
77. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
78. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and child-pugh score
79. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics
80. A prognostic model for predicting survival in cirrhosis with ascites
81. Organ procurement and transplantation network - HRSA. Final rule with comment period
82. Analysis of waiting time
83. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
84. A model to predict survival in patients with end-stage liver disease
85. MELD and PELD: Application of survival models to liver allocation
86. Predicting the prognosis of chronic liver disease: An evolution from child to MELD. Mayo End-stage Liver Disease
87. Detection and treatment of coronary artery disease in liver transplant candidates